SAB Biotherapeutics (SABS) Treasury Shares (2022 - 2025)
Historic Treasury Shares for SAB Biotherapeutics (SABS) over the last 4 years, with Q3 2025 value amounting to $5.5 million.
- SAB Biotherapeutics' Treasury Shares changed 0.0% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $5.5 million for FY2024, which is 0.0% changed from last year.
- Per SAB Biotherapeutics' latest filing, its Treasury Shares stood at $54665.0 for Q3 2025, which was up 20000.0% from -$54665.0 recorded in Q2 2025.
- In the past 5 years, SAB Biotherapeutics' Treasury Shares registered a high of $546658.0 during Q1 2022, and its lowest value of -$54665.0 during Q4 2023.
- For the 4-year period, SAB Biotherapeutics' Treasury Shares averaged around $207730.2, with its median value being $54665.0 (2022).
- Data for SAB Biotherapeutics' Treasury Shares shows a peak YoY increase of 0.0% (in 2023) and a maximum YoY decrease of 0.0% (in 2023) over the last 5 years.
- SAB Biotherapeutics' Treasury Shares (Quarter) stood at $5.5 million in 2022, then changed by 0.0% to $5.5 million in 2023, then changed by 0.0% to $5.5 million in 2024, then changed by 0.0% to $5.5 million in 2025.
- Its Treasury Shares was $5.5 million in Q3 2025, compared to $5.5 million in Q2 2025 and $5.5 million in Q1 2025.